Hotel-Based Rheumatology, and More

REFERENCES

1. 1.↵
   1. Pincus T,
   2. Yazici Y,
   3. Bergman MJ

   . Hotel-based medicine. J Rheumatol 2008;35:1487–8.

   OpenUrlFREE Full Text
2. 2.↵
   1. Prevoo ML,
   2. van ’t Hof MA,
   3. Kuper HH,
   4. et al

   . Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995;38:44–8.

   OpenUrlCrossRefPubMed
3. 3.↵
   1. Leeb BF,
   2. Haindl PM,
   3. Maktari A,
   4. Nothnagl T,
   5. Rintelen B

   . DAS28 values differ considerably depending on patient’s pain perception and sex. J Rheumatol 2007;34:2382–7.

   OpenUrlAbstract/FREE Full Text
4. 4.↵
   1. Leeb BF,
   2. Andel I,
   3. Sautner J,
   4. Nothnagl T,
   5. Rintelen B

   . The DAS28 in rheumatoid arthritis and fibromyalgia patients. Rheumatology Oxford 2004;43:1504–7.

   OpenUrlAbstract/FREE Full Text
5. 5.↵
   1. Breedveld FC,
   2. Weisman MH,
   3. Kavanaugh AF,
   4. et al

   . The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment. Arthritis Rheum 2006;54:26–37.

   OpenUrlCrossRefPubMed
6. 6.↵
   1. Emery P,
   2. Breedveld FC,
   3. Hall S,
   4. et al

   . Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial. Lancet 2008;372:375–82. Epub 2008 Jul 16.

   OpenUrlCrossRefPubMed
7. 7.
   1. Sokka T,
   2. Pincus T

   . Eligibility of patients in routine care for major clinical trials of anti-tumor necrosis factor alpha agents in rheumatoid arthritis. Arthritis Rheum 2003;48:313–8.

   OpenUrlCrossRefPubMed
8. 8.↵
   1. Furst DE,
   2. Breedveld FC,
   3. Kalden JR,
   4. et al

   . Updated consensus statement on biological agents for the treatment of rheumatic diseases. Ann Rheum Dis 2006;65 Suppl:iii2–15.

   OpenUrlFREE Full Text
9. 9.↵
   1. Zhang W,
   2. Doherty M,
   3. Leeb BF,
   4. et al

   . EULAR evidence based recommendations for the diagnosis of hand osteoarthritis — report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2008 Feb 4. [Epub ahead of print]
10. 10.↵
    1. Hynes RB,
    2. Sacket Dl,
    3. Gray JMA,
    4. Guyett GH

    . Transferring evidence from research into practice. 1. The role of clinical care research evidence in clinical decisions. Evidence Based Medicine 1996;1:196–7.

    OpenUrlAbstract/FREE Full Text